Herpes Simplex - Epidemiology Forecast to 2027 Covering Market Drivers & Barriers - ResearchAndMarkets.com

DUBLIN--()--The "Herpes Simplex -Epidemiology Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

This report delivers an in-depth understanding of the disease, historical & forecast epidemiology of HSV infections in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

HSV infections Epidemiology

The HSV Infections epidemiology division provide insights about historical and current patient pool and forecast trends for every 7 major countries. The epidemiology data for HSV Infections is studied through all possible divisions to give a better understanding about the disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

HSV Infections Epidemiology Segmentation

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [total prevalent cases, prevalent cases by types (Genital Herpes and Herpes Labialis), diagnosed prevalence] of HSV infections in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.

The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

According to this research, total prevalent population of HSV infections in 7 major markets was estimated to be about 228,552,199 in 2016.

Key Strengths

  • 10 Year Forecast of HSV infections epidemiology
  • 7MM Coverage
  • Total Prevalent Cases of HSV infections
  • Prevalent Cases according to segmentation: HSV infections by clinical types (Genital Herpes and Herpes Labialis) in 7MM
  • Diagnosed cases of HSV infections

Key Assessments

  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Key Topics Covered

1. Key Insights

2. Disease Background and Overview: Herpes Simplex Virus (HSV)

3. Epidemiology and Patient Population

4. Key Findings

5. Country Wise-Epidemiology of Herpes Simplex Virus (HSV)

6. Market Drivers of HSV

7. Market Barriers of HSV

8. Appendix

9. Report Methodology

10. Capabilities

For more information about this report visit https://www.researchandmarkets.com/research/pq9ff6/herpes_simplex?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs